Product
Lipiodol
Name
LIPIODOL
INN Name
ethiodized oil
FDA Approved
Yes
6 clinical trials
1 organization
3 indications
1 document
Indication
Hepatocellular CarcinomaIndication
Osteoarthritis, KneeIndication
InfertilityClinical trial
Phase I/II Randomized, Double-Blind, First-in-Human Study of T-ACE Oil by Trans-Catheter Arterial Embolization or ChemoEmbolization (TAE/TACE) in Patients With Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma Through Image-guided Locoregional TherapyStatus: Not yet recruiting, Estimated PCD: 2027-08-31
Clinical trial
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for Hepatocellular Carcinoma (HCC)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Prospective Study of the Safety and Efficacy of the Use of a Lipiodol Emulsion for the Embolization of Inflammatory Hypervascularizations Observed in Patients With Joint or Abarticular Knee PainStatus: Completed, Estimated PCD: 2022-06-20
Clinical trial
Pharmacogenetic Study in Hepatocellular Carcinoma Patients Underwent TACEStatus: Completed, Estimated PCD: 2023-03-31
Clinical trial
Tubal Flushing With Oil-based Contrast During HSG in Subfertile Women: Is Early Flushing Effective and Cost-effective as Compared to Delayed Flushing? - H2Oil-timing StudyStatus: Recruiting, Estimated PCD: 2025-12-01
Document
DailyMed Label: LIPIODOLOrganization
Guerbet LLC